期刊文献+

不同程度冠状动脉病变患者的血管性假血友病因子检测 被引量:1

The level of plasma von Willebrand factor in patients with different degrees of coronary artery lesions
下载PDF
导出
摘要 目的探讨不同程度冠脉病变患者的血管性假血友病因子(von Willebrand factor,vwF)水平。方法检测111例冠心病(CHD)及25例非CHD患者的血浆vWF水平。对所有人选患者行冠脉造影检查,将CHD患者根据冠状动脉病变支数分为单支、双支和多支病变组;根据冠状动脉损伤形态分为A型低危病变组、B型中危病变组和C型高危病变组;分析血浆vWF水平与冠状动脉病变的范围及程度的关系。结果CHD多支病变组的血浆vWF水平较单支病变组、双支病变组明显升高[(197.42±6.57)%比(135.24±21.56)%、(170.94±15.75)%,P〈0.01、P〈0.05];双支病变组的血浆vWF水平较单支病变组也明显升高(P〈0.05);对照组与单支病变组的血浆vWF水平差异无统计学意义。C型病变组vwF高于A型、B型病变组[(195.25±33.71)%比(132.10±28.26)%、(161.13±37.41)%,19〈0.01],B型病变组高于A型病变组(P〈0.01)。结论血浆vwF水平能反映冠脉病变的范围及程度。 Objective To detect the plasma levels of von Willebrand factor (vWF) in patients with dif- ferent degrees of coronary artery lesions. Methods 111 patients with CHD were enrolled in this study, 25 patients without CHD as control group. Plasma levels of vWF were detected for all patients before coronary arteriog- raphy. The correlations of the number of impaired coronary arteries (CA), the level of coronary stenosis with levels of vWF were compared. Results The level of vWF was significantly higher in patients who had complex lesions compared with those who had simple or no lesions (P〈0.05 or P〈0.01 ). Conclusion Plasma levels of vWF are significantly associated with more complex lesions.
出处 《中国心血管病研究》 CAS 2011年第8期580-582,共3页 Chinese Journal of Cardiovascular Research
关键词 冠状动脉疾病 冠状动脉造影 血管性假血友病因子 Coronary heart disease Coronary arteriography Von Willebrand factor(vWF)
  • 相关文献

参考文献6

  • 1Ryan TJ,Faxon DP,Gunnar RM,et al.Guidel ines for percutaneous transluminal coronary angioplasty.A report of the American College of Cardiology American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommitt ee on Percutaneous Transluminal Coronary Angioplasty).Circulation,1988,78:486-502.
  • 2Blann AD,Taberner DA.A reliable marker of end othelial cell dysfunction Dose it exist ? Br J Haematol,1995,90:244.
  • 3陈珍严,柳俊,马虹.体外反搏对冠心病患者血浆vWF和sICAM-1水平的影响[J].中国心血管病研究,2005,3(6):411-413. 被引量:7
  • 4Mody NA,Lomakin O,Doggett TA,et al.Mechanics of transient platelet adhesion to von Willebrand factor under flow.Biophys J,2005,88:1432-1443.
  • 5Lee KW,Lip GY,Tayebjee M,et al.Circulating endothelial cells,von Willebrand factor,interleukin 6,and prognosis in patients with acute coronary syndromes.Blood,2005,105:526-532.
  • 6高晓慧,杨新春,王乐丰,崔亮,葛永贵,王红石,倪祝华,李惟铭,徐立,刘宇.冠状动脉粥样硬化性心脏病单支病变和多支病变的血管壁结构的对比研究[J].中国循环杂志,2006,21(6):419-422. 被引量:3

二级参考文献29

  • 1伍贵富,杜志民,张苗青,郑振声.体外反搏对指脉波及主动脉根部压力的影响(摘要)[J].中国循环杂志,1996,11(10):619-619. 被引量:4
  • 2[1]Ross R. Athersclerosis-an inflammatory disease. N Engl J Med, 1999, 340 (2): 115-126
  • 3[2]Giustolisi R, Musso R, Cacciola E, et al. Abnormal plasma levels of factor Ⅷ / von Willebrand factor complex in myocardial infarction-Expression of acute phase reaction or index of vascular endothelial damage.Thromb Haemost, 1984, 51 (3): 408
  • 4[3]Green D, Kucuk O, Haring O, et al. The factor Ⅷ complex in atherosclerosis: effects of aspirin. J Chronic Dis, 1981, 34 (1): 21-26
  • 5[6]Malek AM, Alper SL, Izumo S. Hemodynamic shear stress and its role in atherosclerosis. JAMA, 1999, 282(21) : 2035-2042
  • 6[7]Galbusera M, Zoja C, Donadelli R, et al. Fluid Shear Stress Modulates von Willebrand Factor Release From Human Vascular Endothelium. Blood, 1997, 90 (4):1558-1564
  • 7[8]Langille BL, O'Donnell F. Reductions in arterial diameter produced by chronic decreases in blood flow are endothelium -dependent. Science, 1986, 231 (4736):405 -407
  • 8[10]Lane TA, Lamkin GE, Wancewicz EV. Protein kinase C inhibitors block the enhanced expression of intercellular adhesion molecule-1 on endothelial cells activated by interleukin-1, lypopolysaccharide and tumor necrosis factor. Biochem Biophys Res Commun,1990, 172 (3):1273-1281
  • 9[11]Tsuboi H, Ando J, Krenaga R, et al. Flow stimulates ICAM-1 expression time and shear stress dependently in cultured human endothelial cells. Biochem Biophys Res Commun, 1995, 206 (3) : 988-996
  • 10[12]Hwang S, Ballantyne CM, Sharrett AR, et al. Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Commnities (ARIC) study. Circulation, 1997, 96 (12) :4219-4225

共引文献8

同被引文献21

  • 1王峻 刘颖娴 李向平等.腹部内脏脂肪厚度与冠状动脉狭窄程度的关系.中南大学学报:医学版,2009,:130-132.
  • 2Munk P S, Larsen A I. Inflammation and C—reactive protein incardiovascular disease[J], Tidsskr Nor Laegeforen, 2009 ,129(12):1221-1224.
  • 3Buckley D I,Fu R, Freeman M, et al. C— reactive protein as a riskfactor for coronary heart disease: a systematic review and meta —analyses for the U. S. Preventive Services Task Force[J]. Ann In-tern Med,2009,151(7):483-495.
  • 4Danesh J,Whincup P,Walker M,et al. Fibrin D—dimer and coro-nary heart disease: prospective study and meta —analysis[J]. Circu-lation, 2001,103C19) : 2323-2327.
  • 5Cruz M A, Whitelock J? Don J F. Evaluation of ADAMTS-13 ac-tivity in plasma using recombinant von Willebrand factor A2 domainpolypeptide as substrate[J]. Thromb Haemost ,2003 ,90(6): 1204 —1209.
  • 6Tekin A, Tekin G,Giizelsoy D,et al. Effects of atorvastatin (10mg) on hemostatic and inflammatory parameters in hyperlipidemicpatients with angiographically proven coronary artery disease[J],Am J Cardiol,2004,94(2) :206 —209.
  • 7BaldaSvSarre D,Porta B? Camera M, et al. Markers of inflamma-tion, thrombosis and endothelial activation correlate with carotidIMT regression in stable coronary disease after atorvastatin treat-ment[JJ. Nutr Metab Cardiovasc Dis,2009,19(7) :481 —490.
  • 8Yang EH, McConnell J P, Lennon R J,et al. Lipoprotein —associ-ated phospholipase A2 is an independent marker for coronary endo-thelial dysfunction in humans[J]. Arterioscler Thromb Vase Biol,2006,26(1) :106-111.
  • 9Tsimikas S,Tsironis L D, Tselepis A D. New insights into the roleof lipoprotein(a) — associated lipoprotein — associated phospholipaseA2 in atherosclerosis and cardiovascular disease [J]. ArteriosclerThromb Vase Biol,2007,27(10) :2094-2099.
  • 10Iribarren C,Gross M D, Darbinian J A,et al. Association of lipo-protein—associated phospholipase A2 mass and activity with calci-fied coronary plaque in young adults: the CARDIA study[J]. Arte-rioscler Thromb Vase Biol,2005 ,25(1) : 216 — 221.

引证文献1

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部